These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 29474309)

  • 21. The importance of cytokines analysis in the diagnosis of vitreoretinal lymphoma.
    Frenkel S; Pe'er J; Kaufman R; Maly B; Habot-Wilner Z
    Acta Ophthalmol; 2020 Sep; 98(6):e668-e673. PubMed ID: 31994839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor Control and Visual Acuity Outcomes in Vitreoretinal Lymphoma with and without Sub-Retinal Pigment Epithelium Infiltration: Analysis of 125 Eyes of 70 Patients at a Single Ocular Oncology Center.
    Dalvin LA; Lim LS; Ancona-Lezama D; Mazloumi M; Chang M; Mashayekhi A; Shields CL
    Ophthalmol Retina; 2019 Nov; 3(11):998-1005. PubMed ID: 31358444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comprehensive overview of diagnosis, imaging and treatment of vitreoretinal lymphoma.
    Menean M; Giuffrè C; Cicinelli MV; Marchese A; Modorati G; Bandello F; Miserocchi E
    Eur J Ophthalmol; 2024 Jul; 34(4):931-940. PubMed ID: 37956540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinct Profiles of Soluble Cytokine Receptors Between B-Cell Vitreoretinal Lymphoma and Uveitis.
    Takeda A; Yoshikawa H; Fukuhara T; Hikita S; Hijioka K; Otomo T; Arita R; Hisatomi T; Kimura K; Yoshida S; Kawano Y; Sonoda KH; Ishibashi T
    Invest Ophthalmol Vis Sci; 2015 Nov; 56(12):7516-23. PubMed ID: 26595610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitreoretinal large B- cell lymphoma (VR- LBCL): Clinical and pathological features and treatment outcomes.
    Fadlelseed H; Rhatigan M; Treacy M; Murphy C; O'Neill J; Kilmartin D; Kennedy S
    Pathol Res Pract; 2024 Sep; 261():155500. PubMed ID: 39106590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitreous levels of interleukin-35 as a prognostic factor in B-cell vitreoretinal lymphoma.
    Takeda A; Hasegawa E; Nakao S; Ishikawa K; Murakami Y; Hisatomi T; Arima M; Yawata N; Oda Y; Kimura K; Yoshikawa H; Sonoda KH
    Sci Rep; 2020 Sep; 10(1):15715. PubMed ID: 32973297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single B-Cell Genomic Analyses Differentiate Vitreoretinal Lymphoma from Chronic Inflammation.
    Tan WJ; Wang MM; Castagnoli PR; Tang T; Chan ASY; Lim TS
    Ophthalmology; 2021 Jul; 128(7):1079-1090. PubMed ID: 33221324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for failure of vitrectomy cell block technique in cytological diagnosis of vitreoretinal lymphoma.
    Ito T; Takeda A; Fujiwara K; Hasegawa E; Nakao S; Ohishi Y; Oda Y; Yoshikawa H; Sonoda KH
    Graefes Arch Clin Exp Ophthalmol; 2019 May; 257(5):1029-1036. PubMed ID: 30868235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic methods for primary vitreoretinal lymphoma: A systematic review.
    Huang RS; Mihalache A; Popovic MM; Cruz-Pimentel M; Pandya BU; Muni RH; Kertes PJ
    Surv Ophthalmol; 2024; 69(3):456-464. PubMed ID: 38163550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. INTEREST OF REGULAR ASSAYS OF AQUEOUS HUMOR INTERLEUKIN-10 LEVELS IN MONITORING OF VITREORETINAL LYMPHOMA.
    Metayer C; Kodjikian L; Nguyen AM; Loria O; Chaperon M; Ghesquieres H; Mathis T
    Retina; 2024 Oct; 44(10):1807-1813. PubMed ID: 39287544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitreoretinal Lymphoma with Intraretinal Infiltration, Simulating Retinal Necrosis.
    Guan WX; Peng XY
    Ophthalmol Retina; 2024 Jun; 8(6):571-578. PubMed ID: 38040056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. USE OF A THRESHOLD OF INTERLEUKIN-10 AND IL-10/IL-6 RATIO IN OCULAR SAMPLES FOR THE SCREENING OF VITREORETINAL LYMPHOMA.
    Pochat-Cotilloux C; Bienvenu J; Nguyen AM; Ohanessian R; Ghesquières H; Sève P; Garnier L; Kodjikian L
    Retina; 2018 Apr; 38(4):773-781. PubMed ID: 29135797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Features Predictive of Survival in Patients With Vitreoretinal Lymphoma: Analysis of 70 Patients at a Single Ocular Oncology Center.
    Dalvin LA; Lim LS; Ancona-Lezama D; Mazloumi M; Chang M; Porcu P; Martinez NL; Glass J; Mashayekhi A; Shields CL
    Asia Pac J Ophthalmol (Phila); 2020; 9(2):110-116. PubMed ID: 31923035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Isolated primary vitreoretinal lymphoma (case report)].
    Stoyukhina AS; Korobov EN; Smolin SA
    Vestn Oftalmol; 2024; 140(2. Vyp. 2):94-101. PubMed ID: 38739137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. More than a masquerade syndrome: atypical presentations of vitreoretinal lymphomas.
    AlQahtani A; Touitou V; Cassoux N; Aknin C; Merle-Beral H; Bodaghi B; LeHoang P
    Ocul Immunol Inflamm; 2014 Jun; 22(3):189-96. PubMed ID: 24475870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis and management of vitreoretinal lymphoma: present and future treatment perspectives.
    Kaburaki T; Taoka K
    Jpn J Ophthalmol; 2023 Jul; 67(4):363-381. PubMed ID: 37209195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Experience in a Large Cohort of Patients with Vitreoretinal Lymphoma in a Single Center.
    Giuffrè C; Cicinelli MV; Marchese A; Modorati GM; Brambati M; Ferreri AJM; Calimeri T; Ponzoni M; Bandello F; Miserocchi E
    Ocul Immunol Inflamm; 2021 Apr; 29(3):472-478. PubMed ID: 32845738
    [No Abstract]   [Full Text] [Related]  

  • 38. More Accurate Diagnosis of Vitreoretinal Lymphoma Using a Combination of Diagnostic Test Results: A Prospective Observational Study.
    Tanaka R; Kaburaki T; Taoka K; Karakawa A; Tsuji H; Nishikawa M; Yatomi Y; Shinozaki-Ushiku A; Ushiku T; Araki F
    Ocul Immunol Inflamm; 2022 Aug; 30(6):1354-1360. PubMed ID: 33793360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.
    Cani AK; Hovelson DH; Demirci H; Johnson MW; Tomlins SA; Rao RC
    Oncotarget; 2017 Jan; 8(5):7989-7998. PubMed ID: 28002793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Silent Masquerade: Clinical and Imaging Features of Asymptomatic Vitreoretinal Lymphoma.
    Menean M; Cicinelli MV; Rivolta MC; Marchese A; Modorati G; Bandello F; Miserocchi E
    Am J Ophthalmol; 2024 Nov; 267():153-159. PubMed ID: 38977150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.